MUC5B rs35705950: What Your Genotype Means
The rs35705950 variant is a common genetic change located in the promoter region of the MUC5B gene. It is widely recognized in scientific literature as a significant risk factor for developing idiopathic pulmonary fibrosis (IPF), while paradoxically being associated with improved survival rates in those already diagnosed with the condition.
What each genotype means
Baseline risk profile
This genotype is considered the common or major allele state for this variant. Research indicates that individuals with this genotype do not carry the specific MUC5B promoter variant strongly associated with increased susceptibility to idiopathic pulmonary fibrosis (IPF).
This is the most common genotype in most global populations, though it is less frequent in individuals of European ancestry who carry the risk allele.
Increased susceptibility, improved survival
Carrying one copy of the T-allele is strongly associated with an increased risk of developing idiopathic pulmonary fibrosis (IPF). Interestingly, among individuals who have already been diagnosed with IPF, this genotype is associated with better survival outcomes compared to those without the T-allele. Please discuss any respiratory health concerns or symptoms with your clinician.
This heterozygous genotype is found in a significant portion of the European population, while it remains rare in East Asian populations.
Higher susceptibility, improved survival
Carrying two copies of the T-allele is strongly associated with an increased risk of developing idiopathic pulmonary fibrosis (IPF). Similar to the heterozygous state, research suggests that individuals with this genotype who are diagnosed with IPF may experience improved survival compared to non-carriers. Please discuss any respiratory health concerns or symptoms with your clinician.
This homozygous genotype is the least common of the three in European populations and is very rare in East Asian populations.
Understanding the rs35705950 Variant
The rs35705950 variant is a single nucleotide polymorphism (SNP) located approximately 3,000 base pairs upstream of the MUC5B gene start site. In genetic terms, this is a G to T transversion, meaning the DNA sequence at this specific location contains either a guanine (G) or a thymine (T). Because it sits in the promoter region—the "on-off switch" area of a gene—this variant is thought to influence how much MUC5B protein is produced in the lungs. Researchers have identified this specific site as a cardinal genetic factor in the study of interstitial lung diseases. It is not a mutation that causes a disease directly in the way a rare, single-gene disorder might; rather, it is a common variation that shifts the statistical likelihood of developing certain pulmonary conditions over a lifetime.
The Role of the MUC5B Gene
The MUC5B gene provides instructions for creating a protein called mucin 5B. This protein is a major component of mucus, which is essential for protecting the airways by trapping inhaled particles, bacteria, and debris so they can be cleared from the lungs. In the context of the respiratory system, maintaining the right balance of mucus is critical for lung health. When the MUC5B gene is expressed, it helps maintain the protective lining of the lung's air sacs. Research suggests that the rs35705950 variant may lead to an overproduction or altered regulation of this mucin in the distal airways. While this mucus is intended to protect the lungs, an excess or abnormal accumulation is hypothesized to contribute to the scarring and inflammation characteristic of idiopathic pulmonary fibrosis (IPF).
Research Associations and Evidence
The association between the MUC5B rs35705950 T-allele and idiopathic pulmonary fibrosis is one of the most robust findings in respiratory genetics. Numerous studies have confirmed that individuals carrying the T-allele have a significantly higher susceptibility to developing IPF compared to those who do not. Interestingly, the clinical picture is complex: while the T-allele increases the risk of developing the disease, several studies have observed that patients who carry the T-allele and are subsequently diagnosed with IPF often exhibit better survival outcomes compared to non-carriers. This "survival paradox" remains a subject of active investigation. It is important to note that while the statistical association is strong, the evidence is primarily based on population-level data. These findings describe trends across large groups and cannot predict the specific health trajectory of any single individual.
Population Frequency
The frequency of the rs35705950 variant varies significantly across different ancestral groups. In European populations, the minor T-allele is relatively common, with a frequency typically ranging between 0.09 and 0.12. Conversely, the variant is quite rare in East Asian populations, where the frequency is often reported as less than 0.01. Because of this distribution, the clinical relevance of this variant is most frequently studied and discussed within European-descendant cohorts. These differences highlight the importance of considering ancestry when interpreting genetic data, as the prevalence of specific risk alleles is not uniform across the global human population.
What This Information Means for You
If you have received information about your MUC5B genotype, it is essential to understand that this is not a diagnostic test for idiopathic pulmonary fibrosis. Having the T-allele does not mean you will develop the disease, and not having it does not guarantee you will not. Genetic variants are only one piece of a much larger puzzle that includes environmental exposures, smoking history, age, and other biological factors. If you are concerned about your respiratory health or have a family history of lung disease, the most appropriate step is to consult with a pulmonologist or a genetic counselor. They can help you interpret your results in the context of your personal health history and provide guidance on appropriate screening or monitoring. Never make medical decisions based solely on genetic reports without professional clinical oversight.
How common is this variant?
The minor T-allele has a frequency of approximately 0.09 to 0.12 in European populations, while it is rare in East Asian populations with a frequency of less than 0.01.
Frequently asked questions
Does having the MUC5B T-allele mean I will get IPF?
No. The MUC5B rs35705950 variant is a risk factor, not a direct cause. Many people who carry the T-allele never develop idiopathic pulmonary fibrosis.
Why is the T-allele associated with both higher risk and better survival?
This is known as a survival paradox. While the variant increases the likelihood of developing the disease, researchers believe it may also influence the disease's progression or the body's response to it, leading to better outcomes in those who are already diagnosed.
Should I get tested for the MUC5B variant?
Routine genetic testing for this variant is not currently recommended for the general public. If you have symptoms of lung disease or a strong family history, discuss the necessity of genetic testing with your doctor.
Can I change my MUC5B genotype?
No. Your genotype is determined at conception and cannot be altered. However, you can manage your respiratory health by avoiding known lung irritants like tobacco smoke and air pollution.
Sources & further reading
Educational information only, last refreshed 9/21/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs35705950?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29